Maia Biotechnology Expands Key Phase III Thio-104 Non-Small Cell Lung Cancer Trials in Spain and Portugal
2026-09-23 21:20:17
According to CoinMeta, as reported by Reuters, Maia Biotechnology is expanding its pivotal Phase III Thio-104 non-small cell lung cancer trial in Spain and Portugal.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.